tiprankstipranks
Aarti Drugs Limited (IN:AARTIDRUGS)
:AARTIDRUGS
India Market

Aarti Drugs Limited (AARTIDRUGS) Financial Statements

Compare
0 Followers

Aarti Drugs Limited Financial Overview

Aarti Drugs Limited's market cap is currently ₹35.40B. The company's EPS TTM is ₹16.657; its P/E ratio is 23.00; and it has a dividend yield of 0.26%. Aarti Drugs Limited is scheduled to report earnings on January 22, 2025, and the estimated EPS forecast is ₹3.70. See an overview of income statement, balance sheet, and cash flow financials.
Mar 24Mar 23Mar 22Mar 21Mar 20
Income Statement
Total Revenue₹ 25.09B₹ 27.16B₹ 24.89B₹ 21.55B₹ 18.06B
Gross Profit₹ 3.51B₹ 8.28B₹ 5.04B₹ 6.00B₹ 4.04B
Operating Income₹ 2.78B₹ 2.57B₹ 2.88B₹ 3.88B₹ 2.13B
EBITDA₹ 3.20B₹ 3.12B₹ 3.44B₹ 4.45B₹ 2.71B
Net Income₹ 1.71B₹ 1.66B₹ 2.05B₹ 2.80B₹ 1.41B
Balance Sheet
Cash & Short-Term Investments₹ 89.28M₹ 211.70M₹ 216.12M₹ 88.13M₹ 67.71M
Total Assets₹ 24.32B₹ 24.21B₹ 22.08B₹ 17.66B₹ 15.77B
Total Debt₹ 5.64B₹ 6.09B₹ 5.43B₹ 3.51B₹ 3.89B
Net Debt₹ 5.58B₹ 6.00B₹ 5.21B₹ 3.42B₹ 3.82B
Total Liabilities₹ 11.50B₹ 12.29B₹ 11.72B₹ 8.53B₹ 9.24B
Stockholders' Equity₹ 12.82B₹ 11.92B₹ 10.36B₹ 9.13B₹ 6.52B
Cash Flow
Free Cash Flow₹ 1.33B₹ -304.70M₹ -823.39M₹ 667.19M₹ 2.03B
Operating Cash Flow₹ 3.59B₹ 1.34B₹ 696.36M₹ 1.55B₹ 2.51B
Investing Cash Flow₹ -2.24B₹ -1.64B₹ -1.49B₹ -716.79M₹ -332.09M
Financing Cash Flow₹ -1.36B₹ 165.40M₹ 920.25M₹ -811.29M₹ -2.15B
Currency in INR

Aarti Drugs Limited Earnings and Revenue History

Aarti Drugs Limited Debt to Assets

Aarti Drugs Limited Cash Flow

Aarti Drugs Limited Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis